Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study
van Puijenbroek R., Bosquee L., Meert A-P., Schallier D., Goeminne J-C., Tits G., Collard P., Nackaerts K., Canon J-L., Duplaquet F., Galdermans D., Germonpre P., Azerad M-A., Vandenhoven G., De Greve J., Vansteenkiste J.
Source: Eur Respir J 2007; 29: 128-133
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
van Puijenbroek R., Bosquee L., Meert A-P., Schallier D., Goeminne J-C., Tits G., Collard P., Nackaerts K., Canon J-L., Duplaquet F., Galdermans D., Germonpre P., Azerad M-A., Vandenhoven G., De Greve J., Vansteenkiste J.. Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study. Eur Respir J 2007; 29: 128-133
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: